SCHEMBL4483345

SCHEMBL4483345

CN(C)CCCc1ccc(NC(=C2C(=O)Nc3cc(F)ccc32)c2cccc(CC(=O)O)c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.38
FLT3 P36888 1/20 0.36
LPAR1 Q92633 2/20 0.36
FFAR1 O14842 4/20 0.35
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
TP53 P04637 1/20 0.35
GLA P06280 1/20 0.35
NR1H4 Q96RI1 2/20 0.33
PLK1 P53350 1/20 0.33
SRC P12931 1/20 0.33
NPC1 O15118 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
ALOX15 P16050 1/20 0.33
NFKB1 P19838 1/20 0.33
MAPK1 P28482 1/20 0.33
RAB9A P51151 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4483342 1.00 BACE1 (0.38) BACE1FLT3LPAR1FFAR1KMT2A
SCHEMBL226597 0.95 BACE1 (0.39) BACE1FLT3FFAR1KMT2AMEN1
SCHEMBL226596 0.95 BACE1 (0.39) BACE1FLT3FFAR1KMT2AMEN1
SCHEMBL4493722 0.94 PLK1 (0.38) BACE1FLT3LPAR1NR1H4PLK1
SCHEMBL4493725 0.94 PLK1 (0.38) BACE1FLT3LPAR1NR1H4PLK1
SCHEMBL227346 0.93 FFAR1 (0.39) BACE1FLT3LPAR1FFAR1PLK1
SCHEMBL227345 0.93 FFAR1 (0.39) BACE1FLT3LPAR1FFAR1PLK1
SCHEMBL4493517 0.92 BACE1 (0.40) BACE1FLT3LPAR1KMT2AMEN1
SCHEMBL4493512 0.92 BACE1 (0.40) BACE1FLT3LPAR1KMT2AMEN1
SCHEMBL4485449 0.91 SENP1 (0.35) BACE1FLT3FFAR1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514468-B2 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2009-04-07 US disclosed
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2006-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions KDR, FLT1, EGFR BACE1 1615/4885FLT3 34/4885LPAR1 912/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.